Anxious interactions

Nature Neuroscience

Volumn 13, Issue 5, 2010, Pages 524-526

  González Maeso, Javier ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; MIRTAZAPINE; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C AGONIST;

ANXIETY DISORDER; ENDOCYTOSIS; FEAR; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTERNALIZATION; MAJOR DEPRESSION; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; STRESS; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; MODELS, MOLECULAR; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 77951696771     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn0510-524     Document Type: Short Survey

References (15)

1. Gross C. & Hen R. Nat. Rev. Neurosci. 5, 545-552 (2004).
2. Magalhaes, A.C. et al. Nat. Neurosci. 13, 622-629 (2010).
3. Croom, K.F. et al. CNS Drugs 23, 427-452 (2009).
4. Weisstaub, N.V. et al. Science 313, 536-540 (2006).
5. Vale, W. et al. Science 213, 1394-1397 (1981).
6. Arzt, E. & Holsboer, F. Trends Pharmacol. Sci. 27, 531-538 (2006).
7. Valdez, G.R. CNS Drugs 20, 887-896 (2006).
8. Rosenbaum, D.M. et al. Nature 459, 356-363 (2009).
9. Koenig, J.A. & Edwardson, J.M. Trends Pharmacol. Sci. 18, 276-287 (1997).
10. Lopez-Gimenez, J.F. et al. Mol. Pharmacol. 74, 1278-1291 (2008).
11. Sorkin, A. & Von Zastrow, M. Nat. Rev. Mol. Cell Biol. 10, 609-622 (2009).
12. Kalueff, A.V. et al. Behav. Brain Res. 179, 1-18 (2007).
13. Cryan, J.F. & Holmes, A. Nat. Rev. Drug Discov. 4, 775-790 (2005).
14. Milligan, G. Br. J. Pharmacol. 158, 5-14 (2009).
15. Gavarini, S. et al. Biol. Cell 96, 373-381 (2004).